Vaccine prices will fall in a free market

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

THERE is a growing consensus that one or more Covid-19 vaccines will become available at some point in early 2021. Within a year, many people in the United States, and some other countries, will be vaccinated. For some childhood diseases, the development of a vaccine was by itself decisive. But this may not be true of Covid-19, because adoption could be slow or effectiveness wane over time - or both. Read more at The Business Times.

For Covid-19, adoption of a vaccine will be slow, effectiveness will wane over time, or both, implying that the need for testing will be ongoing.

In addition to progress towards a vaccine, virus testing at scale has to be made much cheaper, so that it becomes available to everyone, whatever their income level.THERE is a growing consensus that one or more Covid-19 vaccines will become available at some point in early 2021. Within a year, many people in the United States, and some other countries, will be vaccinated. For some childhood diseases, the development of a vaccine was by...

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca resumes COVID-19 vaccine trial in Japan, in talks with USBritish drugmaker AstraZeneca said on Friday clinical trials of its experimental COVID-19 vaccine resumed in Japan, while adding that it remains ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Germany approves third trial of Covid-19 vaccine candidateBERLIN (REUTERS) - Unlisted biotech firm IDT Biologika has won approval from Germany's vaccine regulator to become the third German company after BioNTech and CureVac to launch human trials of an experimental coronavirus vaccine in the country.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Britain expects Covid-19 vaccine roll-out in less than 3 months: The TimesLONDON (REUTERS) - A mass roll-out of a Covid-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Covid-19 vaccine roll-out expected in less than three months in UK: The Times[LONDON] A mass roll-out of a Covid-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists. Read more at The Business Times.
Source: BusinessTimes - 🏆 15. / 51 Read more »

COVID-19: Jobs haemorrhaging persists even as US economy recoversWASHINGTON: Flight attendant Kristine Lambiris kept working after her husband lost his job when the coronavirus shut businesses across the United ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Australia's COVID-19 hotspot state Victoria says daily cases near four-month lowSYDNEY: New daily COVID-19 cases in Australia's hotspot state Victoria have fallen to a near four-month low, authorities said on Friday (Oct 2), ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »